OPEN Health has launched a new specialist Learning & Development (L&D) team that will further expand its existing internal training offerings in the pharmaceutical industry.
Open Health has joined forces with health economics and outcomes research (HEOR) company Pharmerit International in a move that strengthens its existing market access capabilities.
OPEN Health has restructured its eight businesses into four specialist practices, in a move that will see it retire names such as LEC, Reynolds-MacKenzie and Harvey Walsh.